Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7459
-0.0441 (-5.58%)
Apr 15, 2026, 4:00 PM EDT - Market closed
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $18.6 million as of April 15, 2026. Its market cap has increased by 428.96% in one year.
Market Cap
18.60M
Enterprise Value
-36.56M
1-Year Change
428.96%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $18.60M, a decrease of -71.51%. That is a compound annual growth rate of -23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 18.60M | -37.55% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 21.75M |
| Quantum BioPharma | 21.04M |
| VYNE Therapeutics | 20.82M |
| Cocrystal Pharma | 19.71M |
| Polyrizon | 19.29M |
| Allarity Therapeutics | 18.82M |
| Citius Pharmaceuticals | 18.24M |
| OSR Holdings | 17.86M |